The landscape of metabolic management is rapidly changing , with the emergence of dual GIP and GLP-1 receptor agonists. Both The Tirzepatide and Retatru tide represent key advancements; Tirzepatid already https://arranlejk912705.keepwritingblog.com/597025/tirzepatide-retatrutide-a-new-metabolic-duo